{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:08:17Z","timestamp":1791976097738,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02796-0","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:33:22Z","timestamp":1749756802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hyaluronic acid-modified theranostic niosomes for targeted Fingolimod delivery and inhibition of triple-negative breast cancer metastasis"],"prefix":"10.1007","volume":"42","author":[{"given":"Zahra","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Kaveh Zenjanab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Pourbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Doustmihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziyeh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Jahanban Esfahlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"issue":"2","key":"2796_CR1","first-page":"171","volume":"104","author":"KP Trayes","year":"2021","unstructured":"Trayes KP, Cokenakes SE. Breast cancer treatment. Am Fam Physician. 2021;104(2):171\u20138.","journal-title":"Am Fam Physician"},{"issue":"2","key":"2796_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","volume":"83","author":"C Katsura","year":"2022","unstructured":"Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med. 2022;83(2):1\u20137.","journal-title":"Br J Hosp Med"},{"key":"2796_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105567","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK, Alimohammadvand S, Doustmihan A, Kianian S, Oskouei BS, Mazloomi M, et al. Paclitaxel for breast cancer therapy: a review on effective drug combination modalities and nano drug delivery platforms. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105567.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"2796_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/0115680266273421231222061620","volume":"24","author":"M Han","year":"2024","unstructured":"Han M, Liu X, Hailati S, Maihemuti N, Nurahmat N, Dilimulati D, et al. Pharmacological effects of FTY720 and its derivatives. Curr Top Med Chem. 2024;24(3):192\u2013200.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"2796_CR5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12935-024-03221-8","volume":"24","author":"SS Alkafaas","year":"2024","unstructured":"Alkafaas SS, Elsalahaty MI, Ismail DF, Radwan MA, Elkafas SS, Loutfy SA, et al. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target. Cancer Cell Int. 2024;24(1):89.","journal-title":"Cancer Cell Int"},{"key":"2796_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/IJN.S494512","volume":"20","author":"P Mouzoura","year":"2025","unstructured":"Mouzoura P, Marazioti A, Gkartziou F, Metsiou DN, Antimisiaris SG. Potential of liposomal FTY720 for bone regeneration: proliferative, osteoinductive, chemoattractive, and angiogenic properties compared to free bioactive lipid. Int J Nanomed. 2025;20:239\u201365.","journal-title":"Int J Nanomed"},{"issue":"1","key":"2796_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-1.15636","volume":"43","author":"LA Yushko","year":"2021","unstructured":"Yushko LA, Sarnatskaya VV, Sakhno LA, Hudenko NV, Paziuk LM, Maslenny VN, et al. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256\/DOX carcinosarcoma. Exp Oncol. 2021;43(1):21\u20135.","journal-title":"Exp Oncol"},{"issue":"5","key":"2796_CR8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s13311-023-01403-2","volume":"20","author":"P Wencel","year":"2023","unstructured":"Wencel P, Blecharz-Klin K, Piechal A, Pyrzanowska J, Mirowska-Guzel D, Strosznajder R. Fingolimod modulates the gene expression of proteins engaged in inflammation and amyloid-beta metabolism and improves exploratory and anxiety-like behavior in obese mice. Neurotherapeutics. 2023;20(5):1388\u2013404.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"2796_CR9","doi-asserted-by":"crossref","first-page":"100926","DOI":"10.1016\/j.tranon.2020.100926","volume":"14","author":"T Rupp","year":"2021","unstructured":"Rupp T, Pelouin O, Genest L, Legrand C, Froget G, Castagn\u00e9 V. Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models. Transl Oncol. 2021;14(1):100926.","journal-title":"Transl Oncol"},{"issue":"45","key":"2796_CR10","doi-asserted-by":"crossref","first-page":"2004098","DOI":"10.1002\/adfm.202004098","volume":"30","author":"MH Ayoubi-Joshaghani","year":"2020","unstructured":"Ayoubi-Joshaghani MH, Seidi K, Azizi M, Jaymand M, Javaheri T, Jahanban-Esfahlan R, et al. Potential applications of advanced nano\/hydrogels in biomedicine: static, dynamic, multi-stage, and bioinspired. Adv Fun Mater. 2020;30(45):2004098.","journal-title":"Adv Fun Mater"},{"issue":"45","key":"2796_CR11","doi-asserted-by":"crossref","first-page":"2104123","DOI":"10.1002\/adfm.202104123","volume":"30","author":"M Niazi","year":"2021","unstructured":"Niazi M, Alizadeh E, Zarebkohan A, Seidi K, Ayoubi-Joshaghani MH, Azizi M, et al. Advanced bioresponsive multitasking hydrogels in the new era of biomedicine. Adv Func Mater. 2021;30(45):2104123.","journal-title":"Adv Func Mater"},{"key":"2796_CR12","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2024.054","author":"M Shahpouri","year":"2024","unstructured":"Shahpouri M, Adili-Aghdam MA, Mahmudi H, Ghiasvand S, Dadashi H, Salemi A, Alimohammadvand S, Roshangar L, Barzegari A, Jaymand M, Jahanban-Esfahlan R. Dual-stage acting dendrimeric nanoparticle for deepened chemotherapeutic drug delivery to tumor cells. Adv Pharm Bull. 2024. https:\/\/doi.org\/10.34172\/apb.2024.054.","journal-title":"Adv Pharm Bull"},{"key":"2796_CR13","doi-asserted-by":"crossref","first-page":"116951","DOI":"10.1016\/j.biopha.2024.116951","volume":"177","author":"S Alimohammadvand","year":"2024","unstructured":"Alimohammadvand S, Kaveh Zenjanab M, Mashinchian M, Shayegh J, Jahanban-Esfahlan R. Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy. Biomed Pharmacother. 2024;177:116951.","journal-title":"Biomed Pharmacother"},{"key":"2796_CR14","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.mtbio.2023.100672","volume":"20","author":"M Azizi","year":"2023","unstructured":"Azizi M, Jahanban-Esfahlan R, Samadian H, Hamidi M, Seidi K, Dolatshahi-Pirouz A, et al. Multifunctional nanostructures: intelligent design to overcome biological barriers. Mater Today Bio. 2023;20:100672.","journal-title":"Mater Today Bio"},{"key":"2796_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138418","author":"H Dadashi","year":"2024","unstructured":"Dadashi H, Mashinchian M, Karimian-Shaddel A, Mohabbat A, Vandghanooni S, Eskandani M, et al. Chitosan nanoparticles loaded with metformin and digoxin synergistically inhibit MCF-7 breast cancer cells through suppression of NOTCH-1 and HIF-1\u03b1 gene expression. Int J Biol Macromol. 2024. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138418.","journal-title":"Int J Biol Macromol"},{"key":"2796_CR16","doi-asserted-by":"crossref","first-page":"104167","DOI":"10.1016\/j.jddst.2023.104167","volume":"80","author":"MFS Jadid","year":"2023","unstructured":"Jadid MFS, Jafari-Gharabaghlou D, Bahrami MK, Bonabi E, Zarghami N. Enhanced anti-cancer effect of curcumin loaded-niosomal nanoparticles in combination with heat-killed saccharomyces cerevisiae against human colon cancer cells. J Drug Deliv Sci Technol. 2023;80:104167.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"2796_CR17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.34.945","volume":"34","author":"R Rajera","year":"2011","unstructured":"Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull. 2011;34(7):945\u201353.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"2796_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12668-024-01647-y","volume":"15","author":"Z Hashemi","year":"2024","unstructured":"Hashemi Z, Beheshtizadeh N, Jaymand M, Jahanban-Esfahlan A, Akbari M, Jahanban ER. Engineered niosomes for cancer therapy: classification, synthesis, and clinical applications. BioNanoScience. 2024;15(1):34.","journal-title":"BioNanoScience"},{"issue":"1","key":"2796_CR19","first-page":"25","volume":"2","author":"VP Chandu","year":"2012","unstructured":"Chandu VP, Arunachalam A, Jeganath S, Yamini K, Tharangini K, Chaitanya G. Niosomes: a novel drug delivery system. Int J Nov Trends Pharm Sci. 2012;2(1):25\u201331.","journal-title":"Int J Nov Trends Pharm Sci"},{"key":"2796_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4020-6289-6_4","volume-title":"Nanomaterials and nanosystems for biomedical applications","author":"NO Sahin","year":"2007","unstructured":"Sahin NO. Niosomes as nanocarrier systems. In: Reza Mozafari M, editor. Nanomaterials and nanosystems for biomedical applications. Cham: Springer; 2007. p. 67\u201381."},{"issue":"9","key":"2796_CR21","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.3390\/ijms22094556","volume":"22","author":"D Ag Seleci","year":"2021","unstructured":"Ag Seleci D, Maurer V, Barlas FB, Porsiel JC, Temel B, Ceylan E, et al. Transferrin-decorated niosomes with integrated InP\/ZnS quantum dots and magnetic iron oxide nanoparticles: dual targeting and imaging of glioma. Int J Mol Sci. 2021;22(9):4556.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2796_CR22","first-page":"448","volume":"2","author":"NS Dey","year":"2011","unstructured":"Dey NS, Rao MB. Quantum dot: novel carrier for drug delivery. Int J Res Pharm Biomed Sci. 2011;2(2):448\u201358.","journal-title":"Int J Res Pharm Biomed Sci"},{"issue":"5251","key":"2796_CR23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.271.5251.933","volume":"271","author":"AP Alivisatos","year":"1996","unstructured":"Alivisatos AP. Semiconductor clusters, nanocrystals, and quantum dots. Science. 1996;271(5251):933\u20137.","journal-title":"Science"},{"issue":"11","key":"2796_CR24","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1039\/C8AN00222C","volume":"143","author":"L Cui","year":"2018","unstructured":"Cui L, Li C-c, Tang B, Zhang C-y. Advances in the integration of quantum dots with various nanomaterials for biomedical and environmental applications. Analyst. 2018;143(11):2469\u201378.","journal-title":"Analyst"},{"issue":"1","key":"2796_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, et al. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 2020;18(1):59.","journal-title":"Cell Commun Signal"},{"key":"2796_CR26","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s11095-012-0839-9","volume":"29","author":"Y-J Jin","year":"2012","unstructured":"Jin Y-J, Termsarasab U, Ko S-H, Shim J-S, Chong S, Chung S-J, et al. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Pharm Res. 2012;29:3443\u201354.","journal-title":"Pharm Res"},{"key":"2796_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function and association with the malignant process. Adv Cancer Res. 1997;71:241\u2013319.","journal-title":"Adv Cancer Res"},{"key":"2796_CR28","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s11095-014-1339-x","volume":"31","author":"I Youm","year":"2014","unstructured":"Youm I, Agrahari V, Murowchick JB, Youan B-BC. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells. Pharm Res. 2014;31:2439\u201352.","journal-title":"Pharm Res"},{"issue":"26","key":"2796_CR29","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1038\/sj.onc.1204435","volume":"20","author":"T Ahrens","year":"2001","unstructured":"Ahrens T, Sleeman JP, Schempp CM, Howells N, Hofmann M, Ponta H, et al. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene. 2001;20(26):3399\u2013408.","journal-title":"Oncogene"},{"issue":"3","key":"2796_CR30","doi-asserted-by":"crossref","first-page":"035015","DOI":"10.1088\/1748-605X\/ad2ed5","volume":"19","author":"MK Zenjanab","year":"2024","unstructured":"Zenjanab MK, Pakchin PS, Fathi M, Abdolahinia ED, Adibkia K. Niosomes containing paclitaxel and gold nanoparticles with different coating agents for efficient chemo\/photothermal therapy of breast cancer. Biomed Mater. 2024;19(3):035015.","journal-title":"Biomed Mater"},{"key":"2796_CR31","doi-asserted-by":"crossref","first-page":"132940","DOI":"10.1016\/j.ijbiomac.2024.132940","volume":"272","author":"H Mahmudi","year":"2024","unstructured":"Mahmudi H, Shahpouri M, Adili-Aghdam MA, Akbari M, Salemi A, Alimohammadvand S, et al. Self-activating chitosan-based nanoparticles for sphingosin-1 phosphate modulator delivery and selective tumor therapy. Int J Biol Macromol. 2024;272:132940.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"2796_CR32","doi-asserted-by":"crossref","first-page":"10875","DOI":"10.1021\/acsomega.3c09782","volume":"9","author":"M Kaveh Zenjanab","year":"2024","unstructured":"Kaveh Zenjanab M, Abdolahinia ED, Alizadeh E, Hamishehkar H, Shahbazi R, Ranjbar-Navazi Z, et al. Hyaluronic acid-targeted niosomes for effective breast cancer chemostarvation therapy. ACS Omega. 2024;9(9):10875\u201385.","journal-title":"ACS Omega"},{"issue":"1","key":"2796_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-025-10241-8","volume":"52","author":"M Fakeri","year":"2025","unstructured":"Fakeri M, Haghi M, Jahanban Esfahlan R, Fathi M, Hosseinpour Feizi MA. Targeted apoptosis in breast cancer cells via niosome-mediated delivery of cyclophosphamide and sodium oxamate. Mol Biol Rep. 2025;52(1):139.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2796_CR34","doi-asserted-by":"crossref","first-page":"055015","DOI":"10.1088\/1748-605X\/ad5d9b","volume":"19","author":"M Sharifi-Azad","year":"2024","unstructured":"Sharifi-Azad M, Kaveh Zenjanab M, Shahpouri M, Adili-Aghdam MA, Fathi M, Jahanban-Esfahlan R. Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomed Mater. 2024;19(5):055015.","journal-title":"Biomed Mater"},{"key":"2796_CR35","doi-asserted-by":"crossref","first-page":"111469","DOI":"10.1016\/j.msec.2020.111469","volume":"118","author":"Z Ranjbar-Navazi","year":"2021","unstructured":"Ranjbar-Navazi Z, Fathi M, Abdolahinia ED, Omidi Y, Davaran S. MUC-1 aptamer conjugated InP\/ZnS quantum dots\/nanohydrogel fluorescent composite for mitochondria-mediated apoptosis in MCF-7 cells. Mater Sci Eng C. 2021;118:111469.","journal-title":"Mater Sci Eng C"},{"key":"2796_CR36","doi-asserted-by":"crossref","first-page":"104449","DOI":"10.1016\/j.jddst.2023.104449","volume":"84","author":"M Eskandani","year":"2023","unstructured":"Eskandani M, Derakhshankhah H, Jahanban-Esfahlan R, Jaymand M. Folate-conjugated pH- and redox-responsive magnetic hydrogel based on tragacanth gum for \u201csmart\u201d chemo\/hyperthermia treatment of cancerous cells. J Drug Deliv Sci Technol. 2023;84:104449.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2796_CR37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1557\/s43578-021-00137-1","volume":"36","author":"R Jahanban-Esfahlan","year":"2021","unstructured":"Jahanban-Esfahlan R, Soleimani K, Derakhshankhah H, Haghshenas B, Rezaei A, Massoumi B, et al. Multi-stimuli-responsive magnetic hydrogel based on tragacanth gum as a de novo nanosystem for targeted chemo\/hyperthermia treatment of cancer. J Mater Res. 2021;36:858\u201369.","journal-title":"J Mater Res"},{"issue":"1","key":"2796_CR38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11033-025-10462-x","volume":"52","author":"A Faraji-Barhagh","year":"2025","unstructured":"Faraji-Barhagh A, Jahandar-Lashaki S, Esfahlan RJ, Alizadeh E. Current nano drug delivery systems for targeting head and neck squamous cell carcinoma microenvironment: a narrative review. Mol Biol Rep. 2025;52(1):369.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"2796_CR39","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139.","journal-title":"Bioinformatics"},{"key":"2796_CR40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, Mariette J, Escudi\u00e9 F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinf. 2014;15:293.","journal-title":"BMC Bioinf"},{"key":"2796_CR41","unstructured":"B G, Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innov. 2024;https:\/\/pubmed.ncbi.nlm.nih.gov\/38706955\/."},{"key":"2796_CR42","unstructured":"B G, Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;https:\/\/pubmed.ncbi.nlm.nih.gov\/37783508."},{"key":"2796_CR43","doi-asserted-by":"crossref","first-page":"100926","DOI":"10.1016\/j.tranon.2020.100926","volume":"14","author":"OP Tristan Rupp","year":"2021","unstructured":"Tristan Rupp OP, Genest L, Legrand C, Froget G, Castagn\u00e9 V. Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models. Transl Oncol. 2021;14:100926.","journal-title":"Transl Oncol"},{"issue":"3","key":"2796_CR44","first-page":"469","volume":"53","author":"TNK Suriyaprakash","year":"2011","unstructured":"Suriyaprakash TNK, Parthiban S, Prabu SL, Sumathi A. Formulation and evaluation of paclitaxel niosome for its improved anti-cancer activity. ACTA Pharm Sci. 2011;53(3):469.","journal-title":"ACTA Pharm Sci"},{"issue":"4","key":"2796_CR45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/abm-2018-0002","volume":"11","author":"PL Yeo","year":"2017","unstructured":"Yeo PL, Lim CL, Chye SM, Ling APK, Koh RY. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed. 2017;11(4):301\u201314.","journal-title":"Asian Biomed"},{"issue":"4","key":"2796_CR46","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"GP Kumar","year":"2011","unstructured":"Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview. Acta Pharm Sin B. 2011;1(4):208\u201319.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2796_CR47","first-page":"3","volume":"4","author":"J Barar","year":"2014","unstructured":"Barar J, Omidi Y. Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer. Bioimpacts. 2014;4(1):3.","journal-title":"Bioimpacts"},{"key":"2796_CR48","doi-asserted-by":"crossref","first-page":"101727","DOI":"10.1016\/j.mtbio.2025.101727","volume":"32","author":"M Pourbakhsh","year":"2025","unstructured":"Pourbakhsh M, Jabraili M, Akbari M, Jaymand M, Jahanban ER. Poloxamer-based drug delivery systems: frontiers for treatment of solid tumors. Mater Today Bio. 2025;32:101727.","journal-title":"Mater Today Bio"},{"key":"2796_CR49","first-page":"101036","volume":"20","author":"M Mazloomi","year":"2025","unstructured":"Mazloomi M, Doustmihan A, Alimohammadvand S, Hamishehkar H, Hamblin MR, Esfahlan RJ. Advanced drug delivery platforms target cancer stem cells. Asian J Pharm Sci. 2025;20:101036.","journal-title":"Asian J Pharm Sci"},{"key":"2796_CR50","doi-asserted-by":"crossref","first-page":"101626","DOI":"10.1016\/j.mtbio.2025.101626","volume":"31","author":"S Karimi","year":"2025","unstructured":"Karimi S, Bakhshali R, Bolandi S, Zahed Z, Mojtaba Zadeh SS, Kaveh Zenjanab M, et al. For and against tumor microenvironment: nanoparticle-based strategies for active cancer therapy. Mater Today Bio. 2025;31:101626.","journal-title":"Mater Today Bio"},{"key":"2796_CR51","doi-asserted-by":"crossref","first-page":"112911","DOI":"10.1016\/j.colsurfb.2022.112911","volume":"220","author":"N Amiryaghoubi","year":"2022","unstructured":"Amiryaghoubi N, Abdolahinia ED, Nakhlband A, Aslzad S, Fathi M, Barar J, et al. Smart chitosan\u2013folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells. Colloids Surf B. 2022;220:112911.","journal-title":"Colloids Surf B"},{"key":"2796_CR52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ijbiomac.2020.04.074","volume":"156","author":"R Jahanban-Esfahlan","year":"2020","unstructured":"Jahanban-Esfahlan R, Derakhshankhah H, Haghshenas B, Massoumi B, Abbasian M, Jaymand M. A bio-inspired magnetic natural hydrogel containing gelatin and alginate as a drug delivery system for cancer chemotherapy. Int J Biol Macromol. 2020;156:438\u201345.","journal-title":"Int J Biol Macromol"},{"key":"2796_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10856-021-06623-6","volume":"32","author":"M Barani","year":"2021","unstructured":"Barani M, Hajinezhad MR, Sargazi S, Rahdar A, Shahraki S, Lohrasbi-Nejad A, et al. In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes. J Mater Sci\u2014Mater Med. 2021;32:1\u201313.","journal-title":"J Mater Sci\u2014Mater Med"},{"key":"2796_CR54","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1208\/s12249-009-9325-z","volume":"10","author":"PS Jadon","year":"2009","unstructured":"Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N. Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech. 2009;10:1186\u201392.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"2796_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/drd_10_4_251","volume":"10","author":"J Varshosaz","year":"2003","unstructured":"Varshosaz J, Pardakhty A, Hajhashemi V-i, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003;10(4):251\u201362.","journal-title":"Drug Deliv"},{"issue":"1","key":"2796_CR56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10544-021-00603-x","volume":"24","author":"H Weng","year":"2022","unstructured":"Weng H, Liu X, Ren Y, Li Y, Li X. Fingolimod loaded niosomes attenuates sevoflurane induced cognitive impairments. Biomed Microdevice. 2022;24(1):5.","journal-title":"Biomed Microdevice"},{"key":"2796_CR57","doi-asserted-by":"crossref","first-page":"851242","DOI":"10.3389\/fphar.2022.851242","volume":"13","author":"T Rezaei","year":"2022","unstructured":"Rezaei T, Rezaei M, Karimifard S, Mahmoudi Beram F, Dakkali MS, Heydari M, et al. Folic acid-decorated ph-responsive nanoniosomes with enhanced endocytosis for breast cancer therapy: in vitro studies. Front Pharmacol. 2022;13:851242.","journal-title":"Front Pharmacol"},{"key":"2796_CR58","doi-asserted-by":"crossref","first-page":"123672","DOI":"10.1016\/j.ijpharm.2023.123672","volume":"649","author":"MV Giuli","year":"2024","unstructured":"Giuli MV, Hanieh PN, Forte J, Fabiano MG, Mancusi A, Natiello B, et al. pH-sensitive niosomes for ATRA delivery: a promising approach to inhibit Pin1 in high-grade serous ovarian cancer. Int J Pharm. 2024;649:123672.","journal-title":"Int J Pharm"},{"issue":"2","key":"2796_CR59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jconrel.2004.12.018","volume":"103","author":"ES Lee","year":"2005","unstructured":"Lee ES, Na K, Bae YH. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release. 2005;103(2):405\u201318.","journal-title":"J Control Release"},{"key":"2796_CR60","first-page":"1","volume":"35","author":"N Kianinejad","year":"2024","unstructured":"Kianinejad N, Razeghifard R, Omidian HH, Omidi Y, Kwon YM. Preparation and characterization of niosomes for the delivery of a lipophilic model drug: comparative stability study with liposomes against phospholipase-A(2). J Liposome Res. 2024;35:1\u201312.","journal-title":"J Liposome Res"},{"issue":"4","key":"2796_CR61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2174\/0126673878259437231031114907","volume":"17","author":"BR Rane","year":"2023","unstructured":"Rane BR, Chavan PY, Kate NS, Jain AS. Development of niosomal vesicles loaded mometasone furoate gel for transdermal delivery and its evaluation. Recent Adv Drug Deliv Formul. 2023;17(4):300\u201313.","journal-title":"Recent Adv Drug Deliv Formul"},{"issue":"3","key":"2796_CR62","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1039\/D3RA07564H","volume":"14","author":"A Ritwiset","year":"2024","unstructured":"Ritwiset A, Maensiri S, Krongsuk S. Insight into molecular structures and dynamical properties of niosome bilayers containing melatonin molecules: a molecular dynamics simulation approach. RSC Adv. 2024;14(3):1697\u2013709.","journal-title":"RSC Adv"},{"issue":"4","key":"2796_CR63","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/pharmaceutics14040747","volume":"14","author":"V Gugleva","year":"2022","unstructured":"Gugleva V, Michailova V, Mihaylova R, Momekov G, Zaharieva MM, Najdenski H, et al. Formulation and Evaluation of hybrid niosomal in situ gel for intravesical co-delivery of curcumin and gentamicin sulfate. Pharmaceutics. 2022;14(4):747.","journal-title":"Pharmaceutics"},{"issue":"4","key":"2796_CR64","doi-asserted-by":"crossref","first-page":"e25887","DOI":"10.1016\/j.heliyon.2024.e25887","volume":"10","author":"A Kattar","year":"2024","unstructured":"Kattar A, Lage EV, Casas M, Concheiro A, Alvarez-Lorenzo C. Langmuir monolayer studies of non-ionic surfactants and DOTMA for the design of ophthalmic niosomes. Heliyon. 2024;10(4):e25887.","journal-title":"Heliyon"},{"issue":"4","key":"2796_CR65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505\u201315.","journal-title":"Mol Pharm"},{"issue":"12","key":"2796_CR66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12032-022-01836-3","volume":"39","author":"M Moghtaderi","year":"2022","unstructured":"Moghtaderi M, Sedaghatnia K, Bourbour M, Fatemizadeh M, Salehi Moghaddam Z, Hejabi F, et al. Niosomes: a novel targeted drug delivery system for cancer. Med Oncol. 2022;39(12):240.","journal-title":"Med Oncol"},{"issue":"10","key":"2796_CR67","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/polym10101133","volume":"10","author":"JH Kim","year":"2018","unstructured":"Kim JH, Moon MJ, Kim DY, Heo SH, Jeong YY. Hyaluronic acid-based nanomaterials for cancer therapy. Polymers. 2018;10(10):1133.","journal-title":"Polymers"},{"issue":"17","key":"2796_CR68","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1039\/C5TB02450A","volume":"4","author":"J Wang","year":"2016","unstructured":"Wang J, Wang F, Li F, Zhang W, Shen Y, Zhou D, et al. A multifunctional poly (curcumin) nanomedicine for dual-modal targeted delivery, intracellular responsive release, dual-drug treatment and imaging of multidrug resistant cancer cells. J Mater Chem B. 2016;4(17):2954\u201362.","journal-title":"J Mater Chem B"},{"issue":"1","key":"2796_CR69","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1038\/s41598-017-05326-9","volume":"7","author":"R Jahanban-Esfahlan","year":"2017","unstructured":"Jahanban-Esfahlan R, Seidi K, Monhemi H, Adli ADF, Minofar B, Zare P, et al. RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice. Sci Rep. 2017;7(1):8126.","journal-title":"Sci Rep"},{"key":"2796_CR70","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2023.5567","author":"Y Tian","year":"2023","unstructured":"Tian Y, Lei Y, Wang Y, Lai J, Wang J, Xia F. Mechanism of multidrug resistance to chemotherapy mediated by P-glycoprotein (Review). Int J Oncol. 2023. https:\/\/doi.org\/10.3892\/ijo.2023.5567.","journal-title":"Int J Oncol"},{"key":"2796_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1\u201316.","journal-title":"Annu Rev Biomed Eng"},{"issue":"17","key":"2796_CR72","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.18632\/oncotarget.7145","volume":"7","author":"C White","year":"2016","unstructured":"White C, Alshaker H, Cooper C, Winkler M, Pchejetski D. The emerging role of FTY720 (Fingolimod) in cancer treatment. Oncotarget. 2016;7(17):23106.","journal-title":"Oncotarget"},{"issue":"10","key":"2796_CR73","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/156652412803833599","volume":"12","author":"M Pitman","year":"2012","unstructured":"Pitman M, Woodcock J, Lopez A, Pitson S. Molecular targets of FTY720 (Fingolimod). Curr Mol Med. 2012;12(10):1207\u201319.","journal-title":"Curr Mol Med"},{"issue":"6","key":"2796_CR74","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1248\/bpb.31.1177","volume":"31","author":"Y Nagaoka","year":"2008","unstructured":"Nagaoka Y, Otsuki K, Fujita T, Uesato S. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells. Biol Pharm Bull. 2008;31(6):1177\u201381.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"2796_CR75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/1061186X.2020.1830408","volume":"29","author":"Z Sadeghi-Ghadi","year":"2021","unstructured":"Sadeghi-Ghadi Z, Ebrahimnejad P, Talebpour Amiri F, Nokhodchi A. Improved oral delivery of quercetin with hyaluronic acid containing niosomes as a promising formulation. J Drug Target. 2021;29(2):225\u201334.","journal-title":"J Drug Target"},{"issue":"4","key":"2796_CR76","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/10717544.2013.838808","volume":"21","author":"NM Zaki","year":"2014","unstructured":"Zaki NM. Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients. Drug Deliv. 2014;21(4):265\u201375.","journal-title":"Drug Deliv"},{"issue":"10","key":"2796_CR77","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1002\/jcp.29576","volume":"235","author":"B Mansoori","year":"2020","unstructured":"Mansoori B, Mohammadi A, Abedi-Gaballu F, Abbaspour S, Ghasabi M, Yekta R, et al. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. J Cell Physiol. 2020;235(10):6817\u201330.","journal-title":"J Cell Physiol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02796-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:39:16Z","timestamp":1751531956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":77,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["2796"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02796-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"256"}}